President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even ...

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two weeks, ramping up his push to reshape the US’s standing in the global ...

The Treasurer says he is evaluating the impact of US drug tariffs on the Pharmaceutical Benefits Scheme but says subsidies ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

CIO & PM of leading sector ETF explains what has been impacting leading names and why he still sees strong long-term ...

Exporters from engineering, plastics and pharmaceuticals said delayed tariff decisions from Washington had stalled expansion plans, pushed back new US orders and clouded short-term growth.

The U.S. is Europe and Britain’s largest export market. About 20% of EU exports go to the U.S. at a value of around $581 billion. Europe’s trade doesn’t immediately have anywhere else to go.

Bessent's victory lap on tariff revenues was premature. And so are hopes that the trade war won't damage commerce and the U.S. economy.

Getinge's quarterly earnings beat market expectations on Friday, driven by organic sales growth across its business areas and regions, as the medical equipment maker seeks ways beyond pricing to ...

Trump's tariff policies have torn up the global trade rule book. With baseline levies of 10% on all US imports and targeted ...